Remtolumab
Modify Date: 2025-12-01 17:11:51
Remtolumab structure
|
Common Name | Remtolumab | ||
|---|---|---|---|---|
| CAS Number | 1791410-27-9 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of RemtolumabRemtolumab (ABT-122) is a dual-variable domain immunoglobulin that neutralises both tumor necrosis factor α (TNFα) and IL-17A. Remtolumab shows dual inhibition of TNFα and IL-17A. Remtolumab can be used for rheumatoid arthritis (RA) research[1][2]. |
| Name | Remtolumab |
|---|
| Description | Remtolumab (ABT-122) is a dual-variable domain immunoglobulin that neutralises both tumor necrosis factor α (TNFα) and IL-17A. Remtolumab shows dual inhibition of TNFα and IL-17A. Remtolumab can be used for rheumatoid arthritis (RA) research[1][2]. |
|---|---|
| Related Catalog | |
| Target |
IL-17A |
| References |
| No Any Chemical & Physical Properties |